Reviva Pharmaceuticals Holdings Stock Market Value
| RVPH Stock | USD 1.14 0.10 8.06% |
| Symbol | Reviva |
Reviva Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reviva Pharmaceuticals. If investors know Reviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reviva Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.08) | Return On Assets (2.34) | Return On Equity (17.95) |
The market value of Reviva Pharmaceuticals is measured differently than its book value, which is the value of Reviva that is recorded on the company's balance sheet. Investors also form their own opinion of Reviva Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reviva Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reviva Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reviva Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Reviva Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Reviva Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reviva Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Reviva Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Reviva Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Reviva Pharmaceuticals.
| 12/06/2022 |
| 11/25/2024 |
If you would invest 0.00 in Reviva Pharmaceuticals on December 6, 2022 and sell it all today you would earn a total of 0.00 from holding Reviva Pharmaceuticals Holdings or generate 0.0% return on investment in Reviva Pharmaceuticals over 720 days. Reviva Pharmaceuticals is related to or competes with Protalix Biotherapeutics, Eyepoint Pharmaceuticals, Sellas Life, In8bio, Cue Biopharma, Lantern Pharma, and ZyVersa Therapeutics. Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializ... More
Reviva Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Reviva Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Reviva Pharmaceuticals Holdings upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.55 | |||
| Information Ratio | 0.0658 | |||
| Maximum Drawdown | 38.61 | |||
| Value At Risk | (9.86) | |||
| Potential Upside | 10.71 |
Reviva Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Reviva Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Reviva Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Reviva Pharmaceuticals historical prices to predict the future Reviva Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0736 | |||
| Jensen Alpha | 0.7001 | |||
| Total Risk Alpha | (0.52) | |||
| Sortino Ratio | 0.0705 | |||
| Treynor Ratio | (0.60) |
Reviva Pharmaceuticals Backtested Returns
Reviva Pharmaceuticals appears to be very risky, given 3 months investment horizon. Reviva Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.0647, which implies the firm had a 0.0647% return per unit of risk over the last 3 months. We have found thirty technical indicators for Reviva Pharmaceuticals, which you can use to evaluate the volatility of the company. Please evaluate Reviva Pharmaceuticals' Semi Deviation of 5.88, coefficient of variation of 1185.32, and Risk Adjusted Performance of 0.0736 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Reviva Pharmaceuticals holds a performance score of 5. The company holds a Beta of -0.97, which implies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Reviva Pharmaceuticals are expected to decrease slowly. On the other hand, during market turmoil, Reviva Pharmaceuticals is expected to outperform it slightly. Please check Reviva Pharmaceuticals' semi variance, as well as the relationship between the daily balance of power and price action indicator , to make a quick decision on whether Reviva Pharmaceuticals' historical price patterns will revert.
Auto-correlation | -0.19 |
Insignificant reverse predictability
Reviva Pharmaceuticals Holdings has insignificant reverse predictability. Overlapping area represents the amount of predictability between Reviva Pharmaceuticals time series from 6th of December 2022 to 1st of December 2023 and 1st of December 2023 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Reviva Pharmaceuticals price movement. The serial correlation of -0.19 indicates that over 19.0% of current Reviva Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.19 | |
| Spearman Rank Test | -0.25 | |
| Residual Average | 0.0 | |
| Price Variance | 1.85 |
Reviva Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Reviva Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Reviva Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Reviva Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Reviva Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Reviva Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Reviva Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Reviva Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Reviva Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Reviva Pharmaceuticals Lagged Returns
When evaluating Reviva Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Reviva Pharmaceuticals stock have on its future price. Reviva Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Reviva Pharmaceuticals autocorrelation shows the relationship between Reviva Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Reviva Pharmaceuticals Holdings.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Reviva Pharmaceuticals is a strong investment it is important to analyze Reviva Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Reviva Pharmaceuticals' future performance. For an informed investment choice regarding Reviva Stock, refer to the following important reports:Check out Reviva Pharmaceuticals Correlation, Reviva Pharmaceuticals Volatility and Reviva Pharmaceuticals Alpha and Beta module to complement your research on Reviva Pharmaceuticals. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Reviva Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.